表观遗传学
红细胞生成
组蛋白乙酰转移酶
甲基转移酶
细胞分化
谱系(遗传)
DNA甲基化
神经发生的表观遗传调控
生物
组蛋白
祖细胞
表观基因组
遗传学
组蛋白甲基转移酶
细胞生物学
甲基化
癌症研究
基因
干细胞
DNA
基因表达
医学
内科学
贫血
作者
Sriram Sundaravel,Ulrich Steidl,Amittha Wickrema
标识
DOI:10.1053/j.seminhematol.2020.12.005
摘要
Erythroid differentiation program is comprised of lineage commitment, erythroid progenitor proliferation, and termination differentiation. Each stage of the differentiation program is heavily influenced by epigenetic modifiers that alter the epigenome in a dynamic fashion influenced by cytokines/humeral factors and are amicable to target by drugs. The epigenetic modifiers can be classified as DNA modifiers (DNMT, TET), mRNA modifiers (RNA methylases and demethylases) and histone protein modifiers (methyltransferases, acetyltransferases, demethylases, and deacetylases). Here we describe mechanisms by which these epigenetic modifiers influence and guide erythroid-lineage differentiation during normal and malignant erythropoiesis and also benign diseases that arise from their altered structure or function.
科研通智能强力驱动
Strongly Powered by AbleSci AI